Veru Inc Kiemelkedően
Mi az Veru Inc Kiemelkedően?
A Kiemelkedően az Veru Inc - 146.384M
Mi a Kiemelkedően meghatározása?
A fennálló részvények egy olyan vállalat vagy pénzügyi eszköz részvényei, amelyeket a befektetők engedélyeztek, bocsátottak ki és vásároltak meg.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Kiemelkedően a Health Care szektor a NASDAQ-on cégekben a Veru Inc -hoz képest
Mit csinál Veru Inc?
the female health company/veru healthcare is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. to realize this goal, veru healthcare has three divisions: pharmaceutical and devices, consumer health products, and public sector. for men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout, and sexual dysfunction. women’s health has product candidates for female sexual health and advanced breast and ovarian cancers and markets fc2, a disposable contraceptive device, to ob gyn physicians and is the only female condom approved by fda that offers dual protection against sexually transmitted infections, including hiv/aids and the zika virus, and unintended pregnancy. since the female health company began distributing fc2 in 2007, the product has been shipped to 144 countries
kiemelkedően -hoz hasonló cégek Veru Inc
- Northrop Grumman nak Kiemelkedően 146.245M van
- Cerberus Cyber Sentinel nak Kiemelkedően 146.254M van
- Dover nak Kiemelkedően 146.333M van
- Sodexo SA nak Kiemelkedően 146.344M van
- Immunovant Inc nak Kiemelkedően 146.367M van
- Sunteck Realty nak Kiemelkedően 146.372M van
- Veru Inc nak Kiemelkedően 146.384M van
- Innovid Corp nak Kiemelkedően 146.407M van
- Resideo Technologies Inc nak Kiemelkedően 146.412M van
- Sunteck Realty nak Kiemelkedően 146.464M van
- OBJ nak Kiemelkedően 146.487M van
- NIBC NV nak Kiemelkedően 146.487M van
- SilverCrest Metals nak Kiemelkedően 146.499M van